Big Endothelin-1 fragment (22-38) (human) peptide
Not For Human Use, Lab Use Only.
Cat.#: 307534
Special Price 215.00 USD
-
Product Name
Big Endothelin-1 fragment (22-38) (human) peptide
-
Documents
Batch to batch variation of the purity
-
Sequence Shortening
VNTPEHVVPYGLGSPRS
-
Sequence
H-Val-Asn-Thr-Pro-Glu-His-Val-Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Arg-Ser-OH
-
Length (aa)
17
-
Peptide Purity (HPLC)
97.9%
-
Molecular Formula
C80H125N23O25
-
Molecular Weight
1809.01
-
CAS No.
124932-61-2
-
Source
Synthetic
-
Form
Powder
-
Description
Big Endothelin-1 fragment (22-38) (human) is the C-terminal 17-amino-acid fragment generated when the 38-residue precursor Big Endothelin-1 (1-38) is cleaved by endothelin-converting enzyme to release mature Endothelin-1 (1-21). In the human circulation, this fragment is cleared very rapidly, with initial and late plasma half-lives of approximately 0.9 and 3.1 minutes, respectively. This rapid elimination reflects efficient fractional extraction across multiple vascular beds, most prominently in skeletal muscle (about 51%), liver (about 44%), and kidney (about 43%), with lower extraction in the brain (about 22%) and lungs (about 14%).
High-performance liquid chromatography of plasma during infusion of Big Endothelin-1 (22-38) reveals the intact fragment together with an earlier-eluting immunoreactive degradation product, indicating that the peptide is metabolized in the circulation; the liver appears particularly effective at degrading the intact fragment. Because of its short half-life relative to Big Endothelin-1 (1-38), the (22-38) fragment is not a stable index of endothelin system secretory activity, whereas the intact (1-38) peptide circulates considerably longer and is extracted mainly by the renal and splanchnic vasculature.
-
Storage Guidelines
Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
-
References
- Hemsén A, Ahlborg G, Ottosson-Seeberger A, Lundberg JM. Metabolism of Big endothelin-1 (1-38) and (22-38) in the human circulation in relation to production of endothelin-1 (1-21). Regul Pept. 1995 Feb 14;55(3):287-97. doi: 10.1016/0167-0115(94)00119-i. PMID: 7761628.
-
About TFA salt
Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.
Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.
Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.
In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.
- Molar Concentration Calculator
- Dilution Calculator
- Percent Concentration Calculator
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Related Products / Services
• Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.
• Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.
• Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"